Future research should integrate STAT5B expression with mutational profiling (e.g., STAT5BN642H, TP53) to better distinguish oncogenic from tumor-suppressive contexts, while also validating findings at the protein level, including phosphorylation status, to clarify its prognostic significance. Here, TP53 is linked to neoplasm.